14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MGNX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

MacroGenics stock price ended at $15.70 on Wednesday, after losing 3.27%.
(Updated on Apr 24, 2024)

Hold candidate since Apr 22, 2024 Gain 1.88% PDF

The MacroGenics stock price fell by -3.27% on the last day (Wednesday, 24th Apr 2024) from $16.23 to $15.70. During the last trading day the stock fluctuated 6.53% from a day low at $15.47 to a day high of $16.48. The price has fallen in 8 of the last 10 days and is down by -13.97% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -125 thousand shares and in total, 522 thousand shares were bought and sold for approximately $8.19 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect MacroGenics stock with a 90% probability to be traded between $13.38 and $21.60 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MGNX Signals & Forecast

There are few to no technical positive signals at the moment. The MacroGenics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $15.97 and $16.39. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -15.18%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for MacroGenics stock

MacroGenics finds support from accumulated volume at $15.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.01 between high and low, or 6.53%. For the last week, the stock has had daily average volatility of 5.78%.

Our recommended stop-loss: $14.70 (-6.36%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (MGNX) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect MacroGenics to open at $15.88, and during the day (based on 14 day Average True Range), to move between $14.55 and $16.85, which gives a possible trading interval of +/-$1.15 (+/-7.34%) up or down from last closing price. If MacroGenics takes out the full calculated possible swing range there will be an estimated 14.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.93 (1.46%) than the support at $15.45 (1.62%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is MacroGenics stock A Buy?

MacroGenics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.576 Hold/Accumulate Unchanged

Predicted Opening Price for MacroGenics of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$15.88 ( 1.17%) $15.70

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MGNX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 16.89 7.60 %
R2 16.51 5.14 %
R1 16.27 3.63 %
Current price: 15.70
Support S1 15.50 -1.29 %
S2 15.26 -2.81 %
S3 14.87 -5.27 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 17.78 13.25 %
R2 17.43 11.02 %
R1 15.93 1.46 %
Current price 15.70
Support S1 15.45 -1.62%
S2 15.27 -2.74%
S3 14.30 -8.92%

FAQ

What is the symbol for MacroGenics Stock and on which exchange is it traded?
The symbol for MacroGenics is MGNX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell MacroGenics Stock?
MacroGenics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy MacroGenics Stock?
MacroGenics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MacroGenics Stock.

What's the current price of MacroGenics Stock?
As of the end of day on the Apr 24, 2024, the price of an MacroGenics (MGNX) share was $15.70.

What is the 52-week high and low for MacroGenics Stock?
The 52-week high for MacroGenics Stock is $21.88 and the 52-week low is $4.29.

What is the market capitalization of MacroGenics Stock?
As of the Apr 24, 2024, the market capitalization of MacroGenics is 973.862M.

When is the next earnings date for MacroGenics?
The upcoming earnings date for MacroGenics is May 14, 2024.
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT